Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Jolee Potts

2PUBLICATIONS
1CO-AUTHORS
Non-Newtonian fluid flows (incl. rheology)Allergy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

Sort by Publication Date:
|Dec 07, 2024
Foamy Cell Angiosarcoma Resembling a Xanthomatous Histiocytic Infiltrate Without Evidence of Vascular Malignancy.

Jolee Potts, George J Harocopos, Aaron J Russell

|Aug 26, 2022
Lichenoid dermatitis preceding Stevens-Johnson syndrome in a patient treated with nivolumab.

Jolee Potts, Rachel Raven Lee, Carolyn A Hilliard

Pageof 1

Frequent Collaborators

1 joint publications

Aaron J Russell

Frequent Collaborators

1 joint publications

Aaron J Russell

Top Related Videos

The <em>In ovo</em> CAM-assay as a Xenograft Model for Sarcoma
12:44

The <em>In ovo</em> CAM-assay as a Xenograft Model for Sarcoma

Published on : Jul 17, 2013

25.4K
Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients
07:42

Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients

Published on : Feb 07, 2021

5.1K
See more related videos

Top Related Videos

The <em>In ovo</em> CAM-assay as a Xenograft Model for Sarcoma
12:44

The <em>In ovo</em> CAM-assay as a Xenograft Model for Sarcoma

Published on : Jul 17, 2013

25.4K
Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients
07:42

Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients

Published on : Feb 07, 2021

5.1K
See more related videos